Skip to Content

BIMI Holdings Inc 63N

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

63N is trading at a 727% premium.
Price
€1.67
Fair Value
€7.50
Uncertainty
Extreme
1-Star Price
€24.31
5-Star Price
€5.93
Economic Moat
Snmvw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 63N is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

BIMI Holdings Inc is a healthcare products and services provider, offering a broad range of healthcare products and related services in the U.S. and Asia. It operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and OTC medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables to private clinics, hospitals, third party pharmacies and other medical device dealers. Medical services include private comprehensive hospitals operating in China.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
296

Valuation

Metric
63N
Price/Earnings (Normalized)
Price/Book Value
0.65
Price/Sales
0.14
Price/Cash Flow
Price/Earnings
63N

Financial Strength

Metric
63N
Quick Ratio
0.32
Current Ratio
1.21
Interest Coverage
−8.68
Quick Ratio
63N

Profitability

Metric
63N
Return on Assets (Normalized)
−15.51%
Return on Equity (Normalized)
−66.75%
Return on Invested Capital (Normalized)
−27.83%
Return on Assets
63N
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Walgreens Boots Alliance Inc
WBA
XnmmtwczMpjd$13.4 Bil
Raia Drogasil SA ADR
RADLY
Pgbqndl$8.2 Bil
Alibaba Health Information Technology Ltd
ALBHF
Lkhzkt$7.2 Bil
Alibaba Health Information Technology Ltd ADR
ALBBY
Wyxqbnp$7.2 Bil
Clicks Group Ltd ADR
CLCGY
Lpvy$4.0 Bil
Sundrug Co Ltd
SDGCF
Rxcwd$2.9 Bil
Sugi Holdings Co Ltd
SGIPF
Ybtgp$2.7 Bil
Redcare Pharmacy NV ADR
SAEYY
Pmt$2.2 Bil
Redcare Pharmacy NV
SHPPF
Hbnd$2.2 Bil
DocMorris AG
ZRSEF
Qdmvxt$816.1 Mil

Sponsor Center